Evidence for cardiomyopathy in familial diabetes mellitus.
about
Mitochondria in the diabetic heartFibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersCrosstalk between the heart and peripheral organs in heart failureDiabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future researchDiabetic cardiomyopathy: bench to bedsideCardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesCarbon monoxide improves cardiac function and mitochondrial population quality in a mouse model of metabolic syndromeMitochondrial morphology in metabolic diseasesDiabetes mellitus reduces the function and expression of ATP-dependent K⁺ channels in cardiac mitochondriaIdentification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissueParticulate matter exposure exacerbates high glucose-induced cardiomyocyte dysfunction through ROS generationInsulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.Diagnostic approaches for diabetic cardiomyopathy.Diabetic Cardiomyopathy in OVE26 Mice Shows Mitochondrial ROS Production and Divergence Between In Vivo and In Vitro ContractilityThe heart in diabetesResveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathyDeficiency of a lipid droplet protein, perilipin 5, suppresses myocardial lipid accumulation, thereby preventing type 1 diabetes-induced heart malfunctionDiabetic cardiomyopathy, causes and effects.Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice.Metabolic cardiomyopathies.Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle.Speckle tracking echocardiography in the diagnosis of early left ventricular systolic dysfunction in type II diabetic mice.Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes.Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study.Coronary microvascular dysfunction in diabetes mellitus: A reviewEffect of intravenous infusion of insulin in diabetics with acute myocardial infarctionEffects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus.Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioningProtein kinase C and the development of diabetic vascular complications.Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response.Myocardial performance in conscious streptozotocin diabetic rats.Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis.Causes and characteristics of diabetic cardiomyopathy.Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI).Alterations in atrial reactivity in a strain of spontaneously diabetic rats.Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human diseaseDiabetes-induced vascular dysfunction involves arginase IHistone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.
P2860
Q24633336-7CFD4DFC-7338-4B15-A657-5B65C5EBD587Q24644869-D55EC924-1E5F-4FE0-9E22-17EB15CDCC4EQ26766491-AB0440A6-4A0C-4921-BA56-70279D6A7ADFQ26782844-BC03FB1F-302D-4E59-9678-DFDA5D1ABA9DQ26997062-000D008F-E1BC-44F7-A9E8-3D613C709375Q27002459-492C6FFA-6480-4847-9D54-3C7E574106BFQ27329935-CDD4799D-46C2-4AA2-89F9-922F8800B06CQ28385060-0D9336FF-5304-4BD7-89AE-FC2D592662A0Q28395463-38577AF1-C4E3-4A4E-9803-C6E39487C35FQ28577919-3D8164E1-C242-478A-B339-9A42A02CE101Q28741716-B53E4C7B-0147-42C2-9904-613505A8D3D0Q30359509-AE880299-5DF3-440B-A79B-F54D9DF65066Q30362092-0769C921-44BE-4F0F-8879-FF4C04F81BE2Q30492750-6D77825E-E4AF-45C0-B291-8497638FC41FQ33606239-99A0E22E-7522-4E48-B95D-AF9809F13F0DQ33727613-55832C8E-6561-43B3-9AEA-628016F94D1EQ33899819-B34F99E1-008A-4CD8-9F9D-346DE5F12618Q34038623-A797FE5A-9399-4C71-8B34-C9CA43177252Q34100205-1C7F1A25-772D-4B1F-BFE2-EE2AEF20B856Q34216280-E4083D85-6AB7-44D0-9B2D-9EEF8E02CB2CQ34258155-6F07450A-89DE-44B5-BB9D-55C5F7C064DFQ34340227-085C47EA-221E-4D2F-B1C1-38A2B381B29EQ34372508-96FB2642-FE87-4A8A-8A8C-278A81D2129AQ34423669-BB00FC24-86AA-4F5B-85FC-8A9E9366C761Q34427072-272AC730-4B8C-49B4-9EB8-D89EB2F6C691Q34486703-66430376-F642-447B-B997-03193775A929Q34506453-2E874361-07AE-44CE-9C6D-189034CB7144Q34520442-E7E2EA76-CFFF-4AC0-A4A4-04286132CA15Q34570516-390352F5-E2AD-4851-B3AF-5F974411A6D2Q34719537-7806EB29-7B77-41E7-8094-B41B3F65774FQ35221216-6FF26FE1-C862-441A-B870-5760F2609772Q35534242-F231CD1F-DD73-4810-893A-BB1D4D298636Q35535273-EA31D999-BBB0-4F66-9C35-4BC99DADC797Q35602720-6B89AC39-17DB-4792-9F91-6D8EA018F508Q35612808-71D70BD8-987E-4F4F-B380-23BD84D46D97Q35651787-B6CF3C5B-118E-4276-82E2-37B7EF8067FBQ35756662-A1C73978-EE17-4E22-A9E3-40FA891FB711Q35863637-9EA0415A-4798-46C5-A2EB-3C1F1EBAAD00Q35906453-CCBF5314-3905-4113-B65C-163C2A447652Q35922922-D4234265-FBA4-48F3-97F7-7CBA60E9C020
P2860
Evidence for cardiomyopathy in familial diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1977
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence for cardiomyopathy in familial diabetes mellitus.
@en
Evidence for cardiomyopathy in familial diabetes mellitus.
@nl
type
label
Evidence for cardiomyopathy in familial diabetes mellitus.
@en
Evidence for cardiomyopathy in familial diabetes mellitus.
@nl
prefLabel
Evidence for cardiomyopathy in familial diabetes mellitus.
@en
Evidence for cardiomyopathy in familial diabetes mellitus.
@nl
P2093
P2860
P356
P1476
Evidence for cardiomyopathy in familial diabetes mellitus.
@en
P2093
Levinson GE
Oldewurtel HA
P2860
P304
P356
10.1172/JCI108843
P407
P577
1977-10-01T00:00:00Z